Harlan Levine, MD
Orthopaedic Surgery · Montvale, NJNPI 1922001361
Payments from drug & device makers
Across 526 payments — averaging $2944.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$1.5M
- Corentec America Inc$20K
- Johnson & Johnson$214
- Davol Inc.$213
- Axogen$197
- Bioventus LLC$143
- plus $425 from 11 others
What the payments were for
- Royalty or licence$1,190,14477%
- Consulting fees$289,96219%
- Travel & lodging$20,2131%
- Food & beverage$6,3410%
- Education$39,1583%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 463 | $1,527,433 |
| Corentec America Inc | 24 | $20,193 |
| Johnson & Johnson | 8 | $214 |
| Davol Inc. | 3 | $213 |
| Axogen | 5 | $197 |
| Bioventus LLC | 5 | $143 |
| Ferring Pharmaceuticals Inc. | 7 | $106 |
| Innovation Technologies Inc | 2 | $77 |
| Globus Medical | 1 | $49 |
| Baxter Healthcare | 1 | $46 |
| Highridge Medical LLC | 1 | $30 |
| Acera Surgical, Inc. | 1 | $30 |
| Sanofi-aventis U.S. LLC | 1 | $20 |
| Zimvie Inc. | 1 | $19 |
| Fidia Pharma USA Inc. | 1 | $17 |
| Heraeus Medical, LLC. | 1 | $16 |
| Endo Pharmaceuticals Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ROSA$1,312,565
- ROSA-Knee$131,941
- PD-Knee-New Product$27,552
- Bencox Hip System$20,094
- LOSPA Knee System$20,094
- Persona$14,072
- Knees Product Portfolio$7,375
- Rosa PKA$7,000
- Robotics$6,625
- Vanguard$5,250
- NexGen$5,250
- MyMobility$1,750
- Connected Health Product Portfolio$1,262
- Oxford-Knees$832
- Hips-None$832
- Persona Revision$459
- Surgiphor$136
- Comprehensive Shoulder System$104
How this compares
$1,548,818 in reported general payments places this provider in the 95th percentile of 587 orthopaedic surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 557 | $1,603 |
| Celecoxib | 65 | $1,013 |
| Amoxicillin | 173 | $194 |
| Azithromycin | 44 | $64 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Montvale
- Michael KellyHackensack$9.7M
- Mark HartzbandParamus$9.4M
- Luke AustinSewell$4.3M
- Randal BetzLawrenceville$3M
- Kenneth MontgomeryMorristown$2.7M
- Zachary PostEgg Harbor Township$1.7M
- Gregg KleinParamus$1.6M
- Jeffrey AbramsPrinceton$1.5M
- Michael AstParamus$1.3M
- David NazarianMarlton$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.